New Strategy to Develop an mRNA Vaccine for Durable Cancer Immunotherapy

摘要

Messenger RNA(mRNA)vaccine is a promising candidate in cancer immunotherapy as it can encode tumor-associated antigens with an excellent safety profile.Unfortunately,the inherent instability of RNA and translational efficiency are major limitations of RNA vaccine.During cancer progression.